Mark Exley

Chief Scientific Officer Lift Biosciences

Seminars

Wednesday 25th February 2026
Scaling Manufacturing of CAR-Neutrophils to Enhance Persistence & Overcome Exhaustion
11:30 am
  • Explore scalable processes for producing CAR-engineered neutrophils with consistent quality and functionality
  • Discuss how optimised culture and differentiation conditions prevent exhaustion and extend therapeutic lifespan
  • Highlight how CAR-neutrophil manufacturing can enable durable, off-the-shelf solutions for solid tumour treatment
Tuesday 24th February 2026
Panel Discussion: Building Stronger Bridges Between Biotechs, Pharma & Investors
11:00 am
  • Share how biotechs can present data and strategy in ways that help investors and pharma make faster, more confident decisions, reducing risk on both sides
  • Highlight how pharma and investors can communicate expectations more clearly ensuring companies design studies and pipelines that are partner-ready
Mark Exley